An Updated View on Temporomandibular Joint Degeneration: Insights from the Cell Subsets of Mandibular Condylar Cartilage
Stem Cells and Development · 01.08.2022 · 31 (15-16) · 445-459
DOI: 10.1089/scd.2021.0324 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cells and Development, erschienen am 01.08.2022. Verfasst von Minglu Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics, Stomatological Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Osteoarthritis, Temporomandibular Joint Disorders. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 171 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthodontics, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Key Laboratory of Oral Disease and Biomedical Sciences, and Stomatological Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Zitieren
APA
Xu, M., Zhang, X., & He, Y. (2022). An Updated View on Temporomandibular Joint Degeneration: Insights from the Cell Subsets of Mandibular Condylar Cartilage. Stem Cells and Development, 31(15-16), 445-459. https://doi.org/10.1089/scd.2021.0324
Vancouver
Xu M, Zhang X, He Y. An Updated View on Temporomandibular Joint Degeneration: Insights from the Cell Subsets of Mandibular Condylar Cartilage. Stem Cells and Development. 2022;31(15-16):445-459. doi:10.1089/scd.2021.0324
BibTeX
@article{Xu2022,
author = {Xu, Minglu and Zhang, Xuyang and He, Yao},
title = {An Updated View on Temporomandibular Joint Degeneration: Insights from the Cell Subsets of Mandibular Condylar Cartilage},
journal = {Stem Cells and Development},
year = {2022},
volume = {31},
number = {15-16},
pages = {445--459},
doi = {10.1089/scd.2021.0324}
}
EUVIMED